Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug…
<!-- Name:DistributionId Value:8798096 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4570 -->…
Browsing Tag
Psychedelic Medicine
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the…
MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge treatments for mental health, has filed a provisional…
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
MIAMI, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc.(OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery technologies for the next generation of…
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for the next generation of mental health…
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for the next generation of mental health…
CATALYST Summit 2022 Returns to Highlight Psychedelic Medicine’s Growing Role in the Medical…
Kingston, Ontario, May 05, 2022 (GLOBE NEWSWIRE) -- CATALYST Presents Foundation (“CATALYST”), the producer of Canada's premiere series of psychedelic medicine conferences, hosts its third annual CATALYST Summit 2022, as a hybrid event…